Prescription EPA Substantially Lowers Cardiovascular Risk in People with T2D
    March 19, 2019

    Prescription EPA Substantially Lowers Cardiovascular Risk in People with T2D

    We spoke with Robert Busch, MD, an endocrinologist at Albany Medical Center about the REDUCE-IT cardiovascular risk reduction clinical trial…
    iGlucose Is Simple, Affordable and Connected
    March 12, 2019

    iGlucose Is Simple, Affordable and Connected

    We spoke with Cliff McIntosh, CEO of Smart Meter, which he has led since 2014, following success in other start-ups…
    Hygieia Rewriting Advanced T2D Care!
    March 5, 2019

    Hygieia Rewriting Advanced T2D Care!

    We spoke with Eran Bashan, CEO, Co-founder, and Chairman of Hygieia based in Livonia, Michigan. See https://hygieia.com/ App is Small…
    Fine Tuning An A1C Strategy
    March 9, 2018

    Fine Tuning An A1C Strategy

    The drug-specific and patient-specific factors described in our earlier coverage become a bit nuanced here.
    Which Combination Drug Therapy is Best for You?
    February 15, 2018

    Which Combination Drug Therapy is Best for You?

    Drug-specific and patient-specific factors determine the most appropriate drug therapies.
    2018 American Diabetes Association’s Practice Standards Recommend GLP-1 Injectables.
    February 1, 2018

    2018 American Diabetes Association’s Practice Standards Recommend GLP-1 Injectables.

    The benefits extend beyond glucose control to protecting cardiovascular health and helping some people lose weight.

    Latest News